It is classified as a triple incretin receptor agonist, meaning it simultaneously targets three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Known for gut protection and tissue healing properties
Kimes, K., Beasley, K., & Dalton, S
Instead of suppressing your appetite or forcing you to eat less, it targets the cellular machinery that tells your fat cells to store or release energy
It is not approved by the FDA or any regulatory authority for human use, veterinary use, clinical administration, therapeutic applications, or diagnostic procedures